UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HIV drug therapy duration; a Swedish real world nationwide cohort study on InfCareHIV 2009-2014

PloS one, 2017-02, Vol.12 (2), p.e0171227-e0171227

2017

Volltextzugriff (PDF)

Predictors of Virological Outcome and Safety in Primary HIV Type 1–Infected Patients Initiating Quadruple Antiretroviral Therapy: QUEST GW PROB3005

Clinical infectious diseases, 2007-08, Vol.45 (3), p.381-390

2007

Volltextzugriff (PDF)

Cutting Edge: The Prevalence of Regulatory T Cells in Lymphoid Tissue Is Correlated with Viral Load in HIV-Infected Patients

The Journal of immunology (1950), 2005-03, Vol.174 (6), p.3143-3147

2005

Volltextzugriff (PDF)

Medical Resource Utilization and Cost of HIV-Related Care in the Highly Active Antiretroviral Therapy Era at a University Clinic in Sweden

PharmacoEconomics, 2010-01, Vol.28 (Suppl 1), p.49-57

2010

Volltextzugriff (PDF)

Reappearance of Founder Virus Sequence in Human Immunodeficiency Virus Type 1-Infected Patients

Journal of Virology, 1999-07, Vol.73 (7), p.6191-6196

1999

Volltextzugriff (PDF)

Impact of HIV type 1 genetic subtype on the outcome of antiretroviral therapy

AIDS research and human retroviruses, 2005-03, Vol.21 (3), p.221-227

2005

Volltextzugriff (PDF)

Recent Origin of Human Immunodeficiency Virus Type 1 Variants in Resting CD4+ T Lymphocytes in Untreated and Suboptimally Treated Subjects

The Journal of infectious diseases, 2001-12, Vol.184 (11), p.1392-1401

2001

Volltextzugriff (PDF)

Long-Term Prognosis following Zidovudine Monotherapy in Primary Human Immunodeficiency Virus Type 1 Infection

The Journal of infectious diseases, 1999-06, Vol.179 (6), p.1549-1552

1999

Volltextzugriff (PDF)

No influence of GB virus C replication on the prognosis in a cohort of HIV-1-infected patients

AIDS (London), 2002-12, Vol.16 (18), p.2482-2485

2002

Volltextzugriff (PDF)

The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients

The Journal of immunology (1950), 2005-03, Vol.174 (6), p.3143-3147

2005

Volltextzugriff (PDF)

Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure

AIDS (London), 2000-10, Vol.14 (15), p.2333-2339

2000

Volltextzugriff (PDF)

Skin and mucosal characteristics of symptomatic primary HIV-1 infection

AIDS patient care and STDs, 1997-04, Vol.11 (2), p.67-70

1997

Volltextzugriff (PDF)

Low Relative Frequencies of CD26+CD4+ Cells in Long-Term Nonprogressing Human Immunodeficiency Virus Type 1-Infected Subjects

Clinical and Diagnostic Laboratory Immunology, 1998-09, Vol.5 (5), p.662-666

1998

Volltextzugriff (PDF)

Recent origin of Human Immunodeficiency Virus type 1 variants in resting CD4 lymphocytes in untreated and suboptimally treated subjects

The Journal of infectious diseases, 2001-12, Vol.184 (11), p.1392

2001

Volltextzugriff (PDF)

Adherence to treatment in Swedish HIV-infected patients

Journal of clinical pharmacy and therapeutics, 2006-12, Vol.31 (6), p.605-616

2006

Volltextzugriff (PDF)

Viral dynamics in primary HIV-1 infection

AIDS (London), 2000, Vol.14 (15), p.2283-2291

2000

Volltextzugriff (PDF)

Differences in adherence and motivation to HIV therapy--two independent assessments in 1998 and 2002

Pharmacy world and science, 2006-08, Vol.28 (4), p.248-256

2006

Volltextzugriff (PDF)

Expansion of CD7(low) and CD7(negative) CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment

Blood, 2004-12, Vol.104 (12), p.3672-3678

2004

Volltextzugriff (PDF)

Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 x 10(6)/1, AIDS, and death from AIDS?

BMJ. British medical journal (International ed.), 1994-12, Vol.309 (6968), p.1535

International edition, 1994

Volltextzugriff (PDF)

Longer survival after HIV infection for injecting drug users than for homosexual men : implications for immunology

AIDS (London), 1997-07, Vol.11 (8), p.1007-1012

1997

Volltextzugriff (PDF)

Characterization of the viral population during primary HIV-1 infection

AIDS (London), 1998-05, Vol.12 (8), p.839-847

1998

Volltextzugriff (PDF)

Zidovudine in the management of primary HIV-1 infection

AIDS (London), 1991-05, Vol.5 (5), p.477-484

1991

Volltextzugriff (PDF)

Evaluation of 14 commercial HIV-1/HIV-2 antibody assays using serum panels of different geographical origin and clinical stage including a unique seroconversion panel

Journal of virological methods, 1998-02, Vol.70 (2), p.139-151

1998

Volltextzugriff (PDF)

Initiation of therapy during primary HIV type 1 infection results in a continuous decay of proviral DNA and a highly restricted viral evolution

AIDS research and human retroviruses, 2001-03, Vol.17 (5), p.409-416

2001

Volltextzugriff (PDF)

Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 x 106/l, AIDS, and death from AIDS?

BMJ, 1994-12, Vol.309 (6968), p.1535-1537

1994

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(65)

Sprache

Englisch
(64)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

HIV drug therapy duration; a Swedish real world nationwide cohort study on InfCareHIV 2009-2014

Predictors of Virological Outcome and Safety in Primary HIV Type 1–Infected Patients Initiating Quadruple Antiretroviral Therapy: QUEST GW PROB3005

Cutting Edge: The Prevalence of Regulatory T Cells in Lymphoid Tissue Is Correlated with Viral Load in HIV-Infected Patients

Medical Resource Utilization and Cost of HIV-Related Care in the Highly Active Antiretroviral Therapy Era at a University Clinic in Sweden

Reappearance of Founder Virus Sequence in Human Immunodeficiency Virus Type 1-Infected Patients

Impact of HIV type 1 genetic subtype on the outcome of antiretroviral therapy

Recent Origin of Human Immunodeficiency Virus Type 1 Variants in Resting CD4+ T Lymphocytes in Untreated and Suboptimally Treated Subjects

Long-Term Prognosis following Zidovudine Monotherapy in Primary Human Immunodeficiency Virus Type 1 Infection

No influence of GB virus C replication on the prognosis in a cohort of HIV-1-infected patients

The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients

Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure

Skin and mucosal characteristics of symptomatic primary HIV-1 infection

Low Relative Frequencies of CD26+CD4+ Cells in Long-Term Nonprogressing Human Immunodeficiency Virus Type 1-Infected Subjects

Recent origin of Human Immunodeficiency Virus type 1 variants in resting CD4 lymphocytes in untreated and suboptimally treated subjects

Adherence to treatment in Swedish HIV-infected patients

Viral dynamics in primary HIV-1 infection

Differences in adherence and motivation to HIV therapy--two independent assessments in 1998 and 2002

Expansion of CD7(low) and CD7(negative) CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment

Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 x 10(6)/1, AIDS, and death from AIDS?

Longer survival after HIV infection for injecting drug users than for homosexual men : implications for immunology

Characterization of the viral population during primary HIV-1 infection

Zidovudine in the management of primary HIV-1 infection

Evaluation of 14 commercial HIV-1/HIV-2 antibody assays using serum panels of different geographical origin and clinical stage including a unique seroconversion panel

Initiation of therapy during primary HIV type 1 infection results in a continuous decay of proviral DNA and a highly restricted viral evolution

Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 x 106/l, AIDS, and death from AIDS?

Suchergebnisse filtern